Literature review demonstrates antifibrotic treatment reduces mortality and acute exacerbations in idiopathic pulmonary fibrosis patients. CONTEXT: A comprehensive literature review of antifibrotic treatment in idiopathic pulmonary fibrosis patients published in Continue Reading
Hungarian real-world research study confirms tolerability of palbociclib similar to registration trials in breast cancer patients. CONTEXT: A retrospective review of 962 Hungarian breast cancer patients published in OncoTargets and Continue Reading
CONTEXT: Report of data presented at ASCO 2021 on cetuximab in metastatic colorectal cancer (mCRC) | US only data IMPACT: Low READ TIME: 2 mins Quality Level Mean [1 – Continue Reading
CONTEXT: Report of a poster presentation at the American College of Cardiology’s 70th Annual Scientific Session on P2Y12 inhibitors, FXa inhibitors and dabigatran. Results of a retrospective analysis of claims databases Continue Reading
CONTEXT: A proper peer reviewed study article on a retrospective study based on an oncology registry in Canada highlighting the differences in outcomes for rural versus urban patients. READ TIME: Continue Reading
CONTEXT: Real world research showing value in rare disease research where RCTs cannot generate the statistical power traditionally needed with so few available patients. New methods to interpret the RWD Continue Reading
IMPACT: Taking insulin and a GLP-1 agonist significantly increases the ability of achievement stable blood sugar levels READ TIME: 2 mins * 1. “Sanofi’s Soliqua combines an insulin with a Continue Reading
EXPERT NOTES: CONTEXT: Peer Reviewed Data, RWE of Effectiveness of Cabozantinib IMPACT: In the largest real-world study to date, cabozantinib was effective in unselected, heavily pretreated patients with mRCC. Initiation Continue Reading
Quick Notes: CONTEXT: Japan, Real-World Data IMPACT: Acceptability of RWD in Regulatory Submissions Time to Read = 2 mins Quotes from Source: 1. “TOKYO — Japan’s health ministry will issue Continue Reading
Quick Notes: *Within the report the “conditional marketing authorisations” and “monitoring in real-life” are the “go to” section to see what the post-authorisation obligations were and what the EMA is Continue Reading
